{
    "2018-04-05": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Edwards Lifesciences Gets CE Mark Approval for Its Centera Valve",
                "features": {
                    "keywords": [
                        "Edwards Lifesciences",
                        "CE Mark",
                        "Centera Valve",
                        "Approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-02-20",
                "original_text": "Johnson & Johnson’s Business Segments in 2017",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Business Segments",
                        "2017"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "consumer health",
                        "medical devices"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Varian’s HyperArc: Driven by Rising Metastatic Brain Cancer?",
                "features": {
                    "keywords": [
                        "Varian",
                        "HyperArc",
                        "Metastatic Brain Cancer"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "oncology",
                        "radiation therapy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}